Our Team
YeTing Liu
YeTing Liu is a senior managing director in the firm’s strategic advisory business. She leads the firm’s Asia cross-border advisory team, covering activities in China, South Korea, India and Australia. She has spent over 13 years in the region, advising across the consumer, energy, healthcare, industrial and technology sectors.
Select deals include advising HUTCHMED on licensing the ex-China rights of Fruquintinib to Takeda; EQT on the sale of its stake in GPA Global to OTPP Asia; GNC on the sale of its assets to Harbin Pharmaceuticals; Sound United on its sale to Masimo; PEP on the sale of Manuka Health to a Hong Kong-based conglomerate; the special committee of Hilton on a 25% investment from HNA Group; Francisco Partners on the sale of Source Photonics; and the special committee of the board of Alibaba on restructuring its interests in the SME loan business.
Prior to joining Evercore, Ms. Liu worked in the M&A group at UBS Investment Bank in New York.
She graduated with highest honors from Rutgers University, earning a B.S. in computer science and finance, and holds an MBA from New York University’s Stern School of Business.